Pacific Biosciences of California Inc (NASDAQ:PACB) currently has a daily average trading volume of 8.79M but it saw 4820017 shares traded in last market. With a market cap of 309.09M USD, the company’s current market price of $1.03 came falling about -1.90 while comparing to the previous closing price of $1.05. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.72 and as low as $0.85.
Over the week, PACB’s stock price is moving -6.36% down while it is -7.21% when we observe its performance for the past one month. Year-to-date it is -43.72% down and over the past year, the stock is showing a downside performance of -42.46%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of -0.17 while estimate for next year EPS is -0.63. In next quarter, company is expected to be making quarterly sales of $39.83M as analysts are expecting the sales for current fiscal year at $156.28M and seeing the company making $185.68M in sales next year. Moreover, analysts are in estimates of $36.45M for current-quarter revenue.
Currently, Pacific Biosciences of California Inc’s total number of outstanding shares is 300.04M with 9.06% of that held by the insiders while 66.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -83.28% and return on equity (ROE) at -177.29%. Stock’s beta reads 2.10. Stock has a price to book (P/B) ratio of 3.37 while price to sale or P/S ratio amounts to 2.03. Its return on asset (ROA) is -51.89% on average.
